8-K
Current Report
Silo Pharma, Inc. Filed Acc 0001213900-15-005409
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading f8072215_pointcapitalinc.htm…